我要投票 沂蒙在玻璃胶行业中的票数:196
· 外 推 电 报 ·
2025-03-03 20:58:18 星期一

【沂蒙是哪个国家的品牌?】

沂蒙是什么牌子?「沂蒙」是 山东省药用玻璃股份有限公司 旗下著名品牌。该品牌发源于山东省淄博市,由创始人扈永在1993-11-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力沂蒙品牌出海!通过在本页面挂载沂蒙品牌的产品链接和联系邮箱,可以提高沂蒙产品曝光!跨境电商爆单神器,目前只要100元/年哦~

山东省药用玻璃股份有限公司位于山东省沂源县城,这里是中国药用玻璃工业发源地之一,也是中国玻璃工业发达的地区。

山东省药用玻璃股份有限公司创立于1970年,以医药、食品、日用品行业为服务对象,生产各种药用、食品、日用品包装材料。2002年1月24日经中国证监会核准发行3200万股A股,并于2002年6月3日挂牌交易。

经过近40年的奋力拼搏,使山东药玻一步步成长为闻名世界的药用包装行业企业,产品市场覆盖32个省、市、自治区,并远销欧、美、俄、日、韩、东南亚等60多个国家和地区,每年为制药、食品、化妆工业提供百亿支各种规格的包装产品,这些产品中有模制抗生素瓶系列产品、管制瓶系列产品、棕色瓶系列产品、中性硼硅玻璃系列产品、输液瓶系列产品、日化瓶系列产品、食品瓶瓷砖 系列产品、丁基橡胶塞系列产品、预灌封注射器系列产品、铝塑盖系列产品、塑料瓶系列产品等,适用于制药工业粉针、水针、输液、口服液、冻干、生物制剂、片剂等不同药品制剂及食品、化妆品的包装需要,并有各种材质、瓶型及规格可供选择。其中公司的主导产品模制抗生素瓶年产量达90多亿支,药用丁基橡胶塞年产量48亿支,销往国内外各制药企业。

此外,山东药玻不断加大投入,采用最新科技,提高制造系列的自动化程度,完善生产工艺和质量控制手段,开发新的品种。引进了美国艾姆哈特行列式制瓶机生产线,实现了产品的自动检验和自动包装,提高了玻璃制品的成品率。强大的技术开发能力,不断满足用户的新需求成为可能。公司已现有科技成果172项,专利技术49项。

积40年从事药用玻璃制造的丰富经验和雄厚实力,山东药玻建立了完善的质量保证体系,对玻璃制造的每一个环节进行了严格的控制,在同行业中率先通过质量体系认证、环境体系认证和安全体系认证,并始终持续的改进保证体系,提升产品的品质,从而取得了和医药工业良好的配合,赢得了医药界人士的认可和赞赏。

英文翻译:Shandong Pharmaceutical Glass Co., Ltd. is located in Yiyuan County, Shandong Province, which is one of the birthplaces of China's pharmaceutical glass industry and the developed area of China's glass industry. Shandong Pharmaceutical Glass Co., Ltd. was founded in 1970, with the pharmaceutical, food, daily necessities industry as the service object, to produce a variety of pharmaceutical, food, daily necessities packaging materials. On January 24, 2002, China Securities Regulatory Commission approved the issuance of 32 million a shares, which was listed for trading on June 3, 2002. After nearly 40 years of hard work, Shandong Pharmaceutical glass has gradually grown into a world-famous pharmaceutical packaging industry enterprise. Its product market covers 32 provinces, cities and autonomous regions, and is exported to more than 60 countries and regions such as Europe, the United States, Russia, Japan, South Korea, Southeast Asia, etc. every year, it provides tens of billions of packaging products of various specifications for pharmaceutical, food and cosmetic industries, among which there are model antibiotics Bottle series products, control bottle series products, brown bottle series products, neutral borosilicate glass series products, infusion bottle series products, daily chemical bottle series products, food bottle ceramic tile series products, butyl rubber plug series products, pre filling syringe series products, aluminum plastic cover series products, plastic bottle series products, etc., suitable for powder injection, water injection, infusion, oral liquid in pharmaceutical industry , freeze-drying, biological agents, tablets and other different pharmaceutical preparations, food and cosmetics packaging needs, and a variety of materials, bottle types and specifications to choose from. Among them, the annual output of the company's leading product molding antibiotic bottles is more than 9 billion, and the annual output of medical butyl rubber plugs is 4.8 billion, which are sold to various pharmaceutical enterprises at home and abroad. In addition, Shandong Pharmaceutical glass has continuously increased investment, adopted the latest technology, improved the automation level of manufacturing series, improved production process and quality control means, and developed new varieties. The production line of American Emhart determinant bottle making machine is introduced to realize the automatic inspection and packaging of products and improve the yield of glass products. It is possible to continuously meet the new needs of users with powerful technology development capabilities. The company has 172 scientific and technological achievements and 49 patented technologies. With 40 years of rich experience and strong strength in pharmaceutical glass manufacturing, Shandong Pharmaceutical glass has established a perfect quality assurance system, strictly controlled every link of glass manufacturing, took the lead in the industry in passing the quality system certification, environmental system certification and safety system certification, and constantly improved the assurance system to improve the quality of products, so as to achieve and The good cooperation of the pharmaceutical industry has won the recognition and appreciation of the people in the pharmaceutical industry.

本文链接: https://www.waitui.com/brand/3548a554a.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

美团:“龙抬头”当天理发订单量较去年同期翻倍增长,理发订单预约量周同比增长270%

36氪获悉,刚过去的3月1日,是农历二月初二“龙抬头”。美团最新数据显示,“龙抬头”当天,理发订单量较去年同期翻倍增长,理发订单预约量周同比增长270%,上午11时-12时、下午16时-18时、晚上19时-21时是全天三个预约高峰时段,北京、上海、成都、杭州、深圳五城热度最高,厦门、沈阳、石家庄、长春、大连订单增速位居前五位。

59分钟前

前2个月全国电动自行车以旧换新突破100万辆

据商务部,全国电动自行车以旧换新工作平稳有序实施,今年1至2月,交售旧车、换购新车各101.9万辆,带动新车销售26.6亿元。电动自行车以旧换新自去年实施以来,累计交售旧车、换购新车各240万辆,带动新车销售约64亿元。(新华社)

59分钟前

汇顶科技:终止发行股份及支付现金购买资产并募集配套资金事项

36氪获悉,汇顶科技公告,公司于2025年3月3日召开董事会和监事会,审议通过终止发行股份及支付现金购买资产并募集配套资金事项。终止原因为公司与交易对方未能就交易对价等商业条款达成一致。公司承诺自终止公告披露之日起1个月内不再筹划重大资产重组事项。此次终止不会对公司生产经营和财务状况造成重大不利影响。

59分钟前

丹麦银行:市场可能持续下调美联储终端利率预期

丹麦银行研究部的助理分析师Asger Wilhelm Dalsjoe在一份报告中表示,美联储终端利率市场定价的向下修正可能还会持续一段时间。终端利率是指美联储停止降息的利率水平。近期公布的美国数据表现疲软,促使货币市场降低了对美联储终端利率的押注。Dalsjoe表示:“我们认为,向下修正可能会再持续一段时间,因为我们的目标是终端利率在3%-3.25%。”根据伦敦证券交易所集团的数据,市场目前预计美联储终端利率将在2026年第二季度达到3.50%左右。(新浪财经)

59分钟前

金银河:近期与Microvast微宏集团在固态电池领域展开深度合作,短期内对公司业绩无重大影响

36氪获悉,金银河公告称,公司股票交易连续三个交易日收盘价格涨幅偏离值累计超过30%,属于股票交易异常波动。公司近期与Microvast微宏集团签订了战略合作协议,在固态电池领域展开深度合作,但具体还需进一步推动和落地,短期内对公司业绩无重大影响。公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息。公司、控股股东及实际控制人不存在关于公司的应披露而未披露的重大事项。

59分钟前

本页详细列出关于时间TIME的品牌信息,含品牌所属公司介绍,时间TIME所处行业的品牌地位及优势。
咨询